Insulin aspart, recombinant Subcutaneous and Lomitapide Mesylate
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Lomitapide Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: lomitapide
Brand name: Juxtapid
Synonyms: Lomitapide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Lomocot
- Insulin aspart, recombinant Subcutaneous-Lomotil
- Insulin aspart, recombinant Subcutaneous-Lomotil (Diphenoxylate and Atropine Solution)
- Insulin aspart, recombinant Subcutaneous-Lomotil (Diphenoxylate and Atropine Tablets)
- Insulin aspart, recombinant Subcutaneous-Lomustine
- Insulin aspart, recombinant Subcutaneous-Long Lasting Nasal Spray
- Lomitapide Mesylate-Insulin degludec
- Lomitapide Mesylate-Insulin Degludec (U-100) Prefilled Pens
- Lomitapide Mesylate-Insulin Degludec (U-100) Vials
- Lomitapide Mesylate-Insulin Degludec (U-200) Prefilled Pens
- Lomitapide Mesylate-Insulin degludec and liraglutide
- Lomitapide Mesylate-Insulin degludec and liraglutide Subcutaneous